Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
ACB
HoldSinkerAurora Cannabis Inc. · Healthcare · Canada · $254M · Avg Vol: $7M/d
COMPANY DESCRIPTION
Aurora Cannabis Inc. is a global leader in the cannabis industry, producing and distributing medical and consumer cannabis products. The company's competitive moat lies in its state-of-the-art, high-efficiency production facilities and its leading market share in the high-margin international medical cannabis segment. It operates as a prominent, vertically integrated player navigating evolving global regulatory frameworks.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2024 | 2025 | 2026 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 160.3M | 195.2M | 209.2M | 232.1M | 9.7% | 227.5M | 216.1M | 232.1M | 0.0% |
| EPS | -29.68 | -27.81 | -1.10 | 0.03 | -1.67 | — | -0.66 | — | — | — |
| Shares | — | 61.9M | 54.5M | 56.2M | 58.9M | -4.8% | 63.3M | — | — | — |
| Debt | 212.3M | 195.1M | 75.9M | 75.7M | 17.3M | -39.5% | 16.4M | — | — | — |
| Equity | — | 479.2M | 405.3M | 410.6M | 370.6M | -6.2% | — | — | — | — |
| Op CF | — | -79.8M | -49.6M | 11.6M | -9.8M | — | -20.3M | — | — | — |
| Inv CF | — | -26.2M | -2.4M | -10.4M | -52.6M | — | — | — | — | — |
| Fin CF | — | 107.0M | -34.7M | -84.0K | 7.1M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ACB are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ACB | Aurora Cannabis Inc.(you) | $254M | 35 | Hold |
| CRDL.TO | Cardiol Therapeutics Inc. | $252M | 23 | Sell |
| WEED.TO | Canopy Growth Corporation | $461M | 24 | Sell |
| TSND.TO | TerrAscend Corp. | $243M | 60 | Hold |
| OGI | Organigram Global Inc. | $171M | 63 | Hold |
| LEEF.CN | Leef Brands Inc. | $58M | 42 | Hold |
| TLRY | Tilray Brands, Inc. | $631M | 13 | Strong Sell |
| HLS.TO | HLS Therapeutics Inc. | $80M | 66 | Buy |
| CPH.TO | Cipher Pharmaceuticals Inc. | $265M | 92 | Strong Buy |
| MLCO.CN | The More Life Company Corp. | $26M | 23 | Sell |
Peer medians: ROE -37.9% · P/E 17.3x · Gross margin 46.2%